Skip to main content
BASKHANBIOPharma Inc. logo

BASKHANBIOPharma Inc. — Investor Relations & Filings

Ticker · 354390 ISIN · KR7354390007 KO Manufacturing
Filings indexed 71 across all filing types
Latest filing 2022-07-26 Director's Dealing
Country KR South Korea
Listing KO 354390

About BASKHANBIOPharma Inc.

http://www.baskhanbio.com/

BASKHANBIOPharma Inc. is a pharmaceutical company focused on pain management and improving patient quality of life. The company engages in the manufacture, sale, and distribution of a diverse product portfolio. Its core offerings include prescription drugs, over-the-counter (OTC) medicines, and medical devices, with a particular emphasis on products used before, during, and after surgical procedures. In addition to its primary pharmaceutical and medical device operations, the company's business areas also encompass health functional foods and cosmetics.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure of insider share transactions (purchases or sales) by company directors or major shareholders. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2022-07-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by executives or major shareholders to disclose their personal shareholdings or changes in ownership. This corresponds to the 'Director's Dealing' category, which covers insider transactions and ownership reporting.
2022-07-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of an executive (Ha Tae-hwan) at Baskhan Bio Pharm. This type of filing is a standard regulatory requirement for reporting insider transactions or changes in ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2022-07-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership and changes in holdings for a specific executive (Yoon Yong-soo) of Baskhan Bio Pharm. This type of filing is a standard regulatory requirement for insider trading/shareholding reporting, which corresponds to the 'Director's Dealing' category.
2022-07-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report insider transactions or changes in share ownership by company directors and executives. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2022-07-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used to disclose insider shareholdings and changes in ownership by directors or major shareholders. This corresponds to the 'Director's Dealing' (DIRS) category, which covers insider trades and ownership reporting.
2022-07-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.